UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Supporting knowledge construction in elementary engineering design

Science education (Salem, Mass.), 2019-07, Vol.103 (4), p.952-978

2019

Volltextzugriff (PDF)

Speech and Gesture Production Provide Unique Insights Into Young Children’s Spatial Reasoning

Child development, 2020-11, Vol.91 (6), p.1934-1952

2020

Volltextzugriff (PDF)

Inconsistent flanker congruency effects across stimulus types and age groups: A cautionary tale

Behavior research methods, 2023-06, Vol.55 (4), p.1778-1817

2023

Volltextzugriff (PDF)

The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor-Related Thyroid Disorders

Cancer immunology research, 2019-07, Vol.7 (7), p.1214-1220

2019

Volltextzugriff (PDF)

Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial

Clinical breast cancer, 2019-12, Vol.19 (6), p.399-404

2019

Volltextzugriff (PDF)

Elementary Students’ Use of Mechanistic Reasoning to Explain Community-Connected Engineering Design Solutions

Journal of science education and technology, 2024-10, Vol.33 (5), p.621-632

2024

Volltextzugriff (PDF)

Abstract OT1-08-05: Phase II trial of GDC-0084 in combination with trastuzumab for patients with HER2-positive breast cancer brain metastases (BCBM)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.OT1-08-05-OT1-08-05

2020

Volltextzugriff (PDF)

A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer

Clinical breast cancer, 2020-06, Vol.20 (3), p.238-245

2020

Volltextzugriff (PDF)

Methods & Strategies: Mapping Students’ Engineering Processes with Design Zones

Science and children, 2021-01, Vol.58 (3), p.61-65

2021

Volltextzugriff (PDF)

Mapping Students' Engineering Processes with Design Zones

Science and children, 2021, Vol.58 (3), p.61-65

2021

Volltextzugriff (PDF)

Design Talks: Fostering whole-class conversations during engineering design units

Science and children, 2024-01, Vol.61 (1), p.64-69

2024

Volltextzugriff (PDF)

Abstract P3-09-16: Fecal microbiome and association with outcomes among patients (pts) receiving eribulin (E) +/- pembrolizumab (P) for hormone receptor positive (HR+) metastatic breast cancer (MBC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-09-16

2020

Volltextzugriff (PDF)

Abstract P4-06-01: Using multi-omic profiling to unravel the complexity of triple-negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P4-P4-06-01

2020

Volltextzugriff (PDF)

Abstract P3-09-10: A phase II study of nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer (mTNBC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-09-10

2020

Volltextzugriff (PDF)

Abstract P3-14-03: A phase 1b study of the CDK4/6 inhibitor ribociclib in combination with the PD-1 inhibitor spartalizumab in patients with hormone receptor-positive metastatic breast cancer (HR+ MBC) and metastatic ovarian cancer (MOC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-14-03

2020

Volltextzugriff (PDF)

Abstract P5-11-04: A phase I/IIb study of palbociclib (PALBO) plus everolimus (EVE) and exemestane (EXE) in hormone-receptor positive (HR+)/HER2- metastatic breast cancer (MBC) after progression on a CDK4/6 inhibitor (CDK4/6i): Results of the phase II study

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-11-04

2020

Volltextzugriff (PDF)

A Phase 1 Dose-Escalation Trial of Radiation Therapy and Concurrent Cisplatin for Stage II and III Triple-Negative Breast Cancer

International journal of radiation oncology, biology, physics, 2021-09, Vol.111 (1), p.45-52

2021

Volltextzugriff (PDF)

Improving Psychology Students’ Attitudes and Anxiety About Statistics

Andrews, Chelsea M

2021

Volltextzugriff (PDF)

Abstract CT050: Expansion cohort of Phase I study of oral sapacitabine and oral seliciclib in patients with metastatic breast cancer and BRCA1/2 mutations

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT050-CT050

2019

Volltextzugriff (PDF)

Nimbus: A phase II study of nivolumab plus ipilimumab in metastatic hypermutated HER2-negative breast cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS1115-TPS1115

2019

Volltextzugriff (PDF)

A phase II study of pembrolizumab in combination with palliative radiotherapy (RT) for hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.1047-1047

2019

Volltextzugriff (PDF)

Abstract P3-10-08: A phase II study of cisplatin and the Wee1 inhibitor adavosertib in metastatic triple-negative breast cancer (mTNBC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-10-08

2020

Volltextzugriff (PDF)

Randomized phase II study of eribulin mesylate (E) with or without pembrolizumab (P) for hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.1004-1004

2019

Volltextzugriff (PDF)

A phase II study of eribulin mesylate in combination with trastuzumab and pertuzumab in patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1034-1034

2017

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Englisch
(160)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Supporting knowledge construction in elementary engineering design

Speech and Gesture Production Provide Unique Insights Into Young Children’s Spatial Reasoning

Inconsistent flanker congruency effects across stimulus types and age groups: A cautionary tale

The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor-Related Thyroid Disorders

Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial

Elementary Students’ Use of Mechanistic Reasoning to Explain Community-Connected Engineering Design Solutions

Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial

Abstract OT1-08-05: Phase II trial of GDC-0084 in combination with trastuzumab for patients with HER2-positive breast cancer brain metastases (BCBM)

A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer

Methods & Strategies: Mapping Students’ Engineering Processes with Design Zones

Mapping Students' Engineering Processes with Design Zones

Design Talks: Fostering whole-class conversations during engineering design units

Abstract P3-09-16: Fecal microbiome and association with outcomes among patients (pts) receiving eribulin (E) +/- pembrolizumab (P) for hormone receptor positive (HR+) metastatic breast cancer (MBC)

Abstract P4-06-01: Using multi-omic profiling to unravel the complexity of triple-negative breast cancer (TNBC)

Abstract P3-09-10: A phase II study of nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer (mTNBC)

Abstract P3-14-03: A phase 1b study of the CDK4/6 inhibitor ribociclib in combination with the PD-1 inhibitor spartalizumab in patients with hormone receptor-positive metastatic breast cancer (HR+ MBC) and metastatic ovarian cancer (MOC)

Abstract P5-11-04: A phase I/IIb study of palbociclib (PALBO) plus everolimus (EVE) and exemestane (EXE) in hormone-receptor positive (HR+)/HER2- metastatic breast cancer (MBC) after progression on a CDK4/6 inhibitor (CDK4/6i): Results of the phase II study

A Phase 1 Dose-Escalation Trial of Radiation Therapy and Concurrent Cisplatin for Stage II and III Triple-Negative Breast Cancer

Improving Psychology Students’ Attitudes and Anxiety About Statistics

Abstract CT050: Expansion cohort of Phase I study of oral sapacitabine and oral seliciclib in patients with metastatic breast cancer and BRCA1/2 mutations

Nimbus: A phase II study of nivolumab plus ipilimumab in metastatic hypermutated HER2-negative breast cancer

A phase II study of pembrolizumab in combination with palliative radiotherapy (RT) for hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Abstract P3-10-08: A phase II study of cisplatin and the Wee1 inhibitor adavosertib in metastatic triple-negative breast cancer (mTNBC)

Randomized phase II study of eribulin mesylate (E) with or without pembrolizumab (P) for hormone receptor-positive (HR+) metastatic breast cancer (MBC)

A phase II study of eribulin mesylate in combination with trastuzumab and pertuzumab in patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC)

Suchergebnisse filtern